多中心多omics集成预测在骨髓甲状腺癌的个性化预后
Yan Zhou1,2,3,4, Yingrui Wang2,3,4, Xiao Shi5,6
1College of Life Sciences, Zhejiang University, Hangzhou, China.
Nature communications
|January 14, 2026
概括
这项研究确定了状甲状腺癌 (MTC) 复发的关键临床和遗传因素. 一个新的机器学习模型整合了多omics数据,以改善风险分层和个性化患者管理.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 蛋白质组学是指蛋白质组学.
背景情况:
- 髓性甲状腺癌 (MTC) 是一种罕见的,具有攻击性的神经内分泌瘤,治疗选择有限,复发率高.
- 目前缺乏对MTC复发的全面风险分层,这阻碍了个性化管理.
研究的目的:
- 使用多omics数据全面分析MTC瘤.
- 确定与MTC复发相关的新型临床,基因组和蛋白质组因素.
- 开发和验证MTC复发风险分层的集成机器学习模型.
主要方法:
- 在452名患者的482个MTC样本上进行了多中心,多omics的分析.
- 使用先进的蛋白质和基因组技术识别蛋白质和突变.
- 开发和验证整合临床,基因组和蛋白质组数据的机器学习模型.
主要成果:
- 确定了重要的临床复发风险因素,包括MTC分级,并发性乳头甲状腺癌和淋巴结转移.
- 相关的特定RET突变 (M918T,S891A) 在零星和遗传MTC中具有高复发风险.
- 发现了与结构复发相关的下调调节E3酶 (CUL4B,TRIM32),并确定了三种不同的分子亚型.
结论:
- 这项多中心,多学科的研究提供了对MTC异质性的更深入的理解.
- 结合临床,基因组和蛋白质组特征的集成机器学习模型显示出强大的复发预测能力.
- 这些发现有助于加强个性化的患者管理和甲状腺髓癌风险分层.
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K